Top Markets
Coin of the day
Elevation Oncology, Inc. Elevation Oncology, Inc.

Elevation Oncology, Inc.

ELEV
Kedudukan dalam Saham #29362
Elevation Oncology, Inc. is a clinical-stage biopharmaceutical company... Elevation Oncology, Inc. is a clinical-stage biopharmaceutical company operating in the United States, committed to developing targeted cancer therapies for patients with specific genetic profiles. Its leading drug candidate is seribantumab, an anti-HER3 monoclonal antibody currently being evaluated in the Phase II CRESTONE trial. This study focuses on treating advanced solid tumors that harbor a neuregulin-1 fusion. The company was established in 2019 and is headquartered in New York, New York.
Harga Saham
$0.365
Disegerakkan terakhir: 2025-08-01
Modal Pasaran
$21.54M
Perubahan (1 hari)
0.00%
Perubahan (1 tahun)
0.00%
Negara
US
Perdagangan Elevation Oncology, Inc. (ELEV)

Kategori

Sejarah pecahan saham untuk Elevation Oncology, Inc. (ELEV)
Saham Elevation Oncology, Inc. (simbol: ELEV) telah mengalami sejumlah 0 pecahan saham.
Pecahan saham terkini berlaku pada Aug 19, 2026.
Satu saham ELEV yang dibeli sebelum Aug 19, 2026 kini bersamaan dengan 0 saham ELEV.
Senarai pecahan saham
Tahun Pecahan Gandaan Gandaan Kumulatif
Tidak cukup data untuk tarikh yang disediakan.
Pecahan saham untuk syarikat pesaing atau serupa
Syarikat Bilangan pecahan saham Gandaan Kumulatif Negara
1 x2
US
0 -
NL
0 -
US
1 x3
AU
0 -
CH